# EDGAR Filing Document

**Accession Number:** 0000740260
**File Stem:** 0000740260-25-000228
**Filing Date:** 2025-7
**Character Count:** 65397
**Document Hash:** ba23c03f964eeb64fee099748d0fb149
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000740260-25-000228.hdr.sgml**: 20250730

**ACCESSION NUMBER**: 0000740260-25-000228

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20250730

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250730

**DATE AS OF CHANGE**: 20250730

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Ventas, Inc.
- **CENTRAL INDEX KEY:** 0000740260
- **STANDARD INDUSTRIAL CLASSIFICATION:** REAL ESTATE INVESTMENT TRUSTS [6798]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 611055020
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-10989
- **FILM NUMBER:** 251167566

**BUSINESS ADDRESS:**
- **STREET 1:** 300 N LASALLE STREET
- **STREET 2:** SUITE 1600
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60654
- **BUSINESS PHONE:** 3126603800

**MAIL ADDRESS:**
- **STREET 1:** 300 N LASALLE STREET
- **STREET 2:** SUITE 1600
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60654

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** VENTAS INC
- **DATE OF NAME CHANGE:** 19980507

?xml version='1.0' encoding='ASCII'? vtr-20250730

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): July 30, 2025

**Ventas, Inc.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-10989** | **61-1055020** |
| (State or other jurisdiction<br>of incorporation) | (Commission<br>File Number) | (IRS Employer<br>Identification No.) |

---

---

| | |
|:---|:---|
| **300 North LaSalle Street, Suite 1600, Chicago, Illinois** | **60654** |
| (Address of principal executive offices) | (Zip Code) |

---

Registrant's telephone number, including area code: **(877) 483-6827**

**Not applicable**

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common stock, $0.25 par value | VTR | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.02. &nbsp;&nbsp;&nbsp;&nbsp;Results of Operations and Financial Condition.**

On July 30, 2025, Ventas, Inc. (the "Company") issued a press release announcing its results of operations for the quarter ended June 30, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated into this Item 2.02 by reference.

The information in this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" with the U.S. Securities and Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as may be expressly set forth by specific reference in such filing.

**Item 9.01.&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.**

---

| | |
|:---|:---|
| **<u>Exhibit Number</u>** | **<u>Description</u>** |
| <u>[99.1](q22025earningsrelease.htm)</u> | Press release issued by the Company on July 30, 2025. |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL). |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | **VENTAS, INC.** | **VENTAS, INC.** |
| Date: July 30, 2025 | By: | <u>/s/ Carey S. Roberts&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> |
|  |  | Carey S. Roberts |
|  |  | Executive Vice President, General Counsel, Ethics and Compliance Officer and Corporate Secretary |

---

## Exhibit 99.1

![ventas-logox2colorxlightbga.jpg](ventas-logox2colorxlightbga.jpg)&nbsp;&nbsp;&nbsp;&nbsp;**Exhibit 99.1**

Ventas, Inc.&nbsp;&nbsp;&nbsp;&nbsp;300 North LaSalle Street, Suite 1600&nbsp;&nbsp;&nbsp;&nbsp;Chicago, Illinois 60654&nbsp;&nbsp;&nbsp;&nbsp;(877) 4-VENTAS&nbsp;&nbsp;&nbsp;&nbsp;www.ventasreit.com

Contact:&nbsp;&nbsp;&nbsp;&nbsp;BJ Grant

(877) 4-VENTAS&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**Ventas Reports 2025 Second Quarter Results**

**CHICAGO** – Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") today reported results for the second quarter ended June 30, 2025.

**<u>CEO Remarks</u>**

"The Company delivered strong earnings growth in the second quarter, led by powerful organic and external growth in our Senior Housing Operating Portfolio," said Debra A. Cafaro, Ventas Chairman and CEO.

"We are experiencing an unprecedented multiyear growth opportunity in senior housing driven by secular demand from a large and growing aging population, historically low new supply and an attractive product offering that is valuable to seniors. Our advantaged platform enables us to drive performance in our existing communities and make compelling investments in senior housing.

"We continue to execute on our 1-2-3 strategy to create value for stockholders. We are pleased to update and improve our full year guidance and increase our expected 2025 investment volume," Cafaro concluded.

**<u>Second Quarter and Other 2025 Highlights</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net Income Attributable to Common Stockholders ("Attributable Net Income") per share of $0.15

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Normalized Funds From Operations\* ("Normalized FFO") per share of $0.87, an increase of 9% compared to the prior year

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Total Company Net Operating Income\* ("NOI") year-over-year growth of 14% and Total Company Same-Store Cash NOI\* year-over-year growth of 7%

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• On a Same-Store Cash NOI\* basis, the senior housing operating portfolio ("SHOP") grew 13% year-over-year, with cash operating revenue growth of 8% and NOI margin growth of 130 basis points

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Year to date, the Company closed $1.1 billion of senior housing investments with attractive financial return expectations, consistent with its stated investment criteria and Right Market, Right Asset, Right Operator<sup>TM</sup> strategy

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Year to date, the Company has settled 16.4 million shares of common stock under outstanding forward sales agreements for gross proceeds of $1.1 billion and currently has $0.7 billion of unsettled equity forward sales agreements outstanding

\*Some of the financial measures throughout this press release are non-GAAP measures. Refer to the Non-GAAP Financial Measures Reconciliation tables at the end of this press release for additional information and a reconciliation to the most directly comparable GAAP measure.

------

Ventas Reports 2025 Second Quarter Results

July 30, 2025

**<u>Second Quarter 2025 Company Results</u>**

For the Second Quarter 2025, reported per share results were:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Quarter Ended June 30,** | **Quarter Ended June 30,** | **Quarter Ended June 30,** | **Quarter Ended June 30,** |
| | **2025** | **2024** | **$ Change** | **% Change** |
| Attributable Net Income | $0.15 | $0.05 | $0.10 | 200% |
| Nareit FFO\* | $0.86 | $0.77 | $0.09 | 12% |
| Normalized FFO\* | $0.87 | $0.80 | $0.07 | 9% |

---

**<u>SHOP Growth</u>**

In the second quarter, SHOP Same-Store Cash NOI increased 13% year-over-year, or 15% year-over-year excluding a $3 million property tax refund received in the second quarter 2024. SHOP Same-Store Cash Operating Revenue\* growth strengthened to 8% year-over-year and was composed of Revenue per Occupied Room growth of 5% and average occupancy growth of 240 basis points.

Second quarter resident demand was robust and broad-based as the key selling season gained traction. Same-store year-over-year average occupancy growth accelerated intra-quarter, with strong June net move ins.

**<u>External Growth Focused on Senior Housing</u>**

Ventas has closed $1.1 billion of senior housing investments year to date. These investments are expected to increase the Company's growth rate on a multiyear basis and generate attractive NOI yields.

The Company is increasing its investment volume expectations for 2025 to $2 billion, up from the prior estimate of $1.5 billion.

**<u>Financial Strength and Flexibility</u>**

The Company's Net Debt-to-Further Adjusted EBITDA\* improved to 5.6x as of the end of the second quarter driven by SHOP segment growth and equity-funded senior housing investments, representing a reduction of 0.4x compared to year-end 2024.

As of June 30, 2025, the Company had $4.7 billion in liquidity, a competitive advantage that supports Ventas's growth and financial flexibility. Liquidity includes availability under its unsecured revolving credit facility, cash and cash equivalents and unsettled equity forward sales agreements outstanding.

- MORE -

------

Ventas Reports 2025 Second Quarter Results

July 30, 2025

**<u>Improved Full Year 2025 Guidance</u>**

The Company is increasing its guidance for the full year. The Company's 2025 guidance contains forward-looking statements and is based on a number of assumptions, including those identified later in this press release; actual results may differ materially. Ventas expects to report 2025 per share Attributable Net Income to common stockholders, Nareit FFO and Normalized FFO within the following ranges:

---

| | | |
|:---|:---|:---|
| | **As of 5/28/25** | **As of 7/30/2025** |
| Attributable Net Income Per Share Range | $0.43 - $0.53 | $0.47 - $0.52 |
| Attributable Net Income Per Share Midpoint | $0.48 | $0.50 |
| Nareit FFO Per Share Range\* | $3.28 - $3.38 | $3.38 - $3.43 |
| Nareit FFO Per Share Midpoint\* | $3.33 | $3.41 |
| Normalized FFO Per Share Range\* | $3.36 - $3.46 | $3.41 - $3.46 |
| Normalized FFO Per Share Midpoint\* | $3.41 | $3.44 |

---

**<u>Full Year 2025 Guidance Commentary Update</u>**

The Company's full year guidance for 2025 Normalized FFO per share is composed primarily of: (1) the benefit of (a) NOI growth in the Company's SHOP segment and (b) accretive senior housing investment activity in 2024 and expected in 2025, partially offset by (2) the impact of higher net interest expense and the dilutive impact of a higher share price. The Company guidance includes completion of $2.0 billion in 2025 investments, with future investments expected to be funded primarily with its existing unsettled forward equity commitments. Certain additional assumptions are set forth in the appendix.

**<u>Investor Presentation</u>**

An Earnings Presentation is posted to the Events & Presentations section of Ventas's website at ir.ventasreit.com/events-and-presentations. Additional information regarding the Company can be found in its Supplemental posted at ir.ventasreit.com. The information contained on, or that may be accessed through, the Company's website, including the information contained in the aforementioned Earnings Presentation and Supplemental, is not incorporated by reference into, and is not part of, this document.

**<u>Second Quarter 2025 Results Conference Call</u>**

Ventas will hold a conference call to discuss this earnings release on Thursday, July 31, 2025 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time).

The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast can be accessed from the Investor Relations section of www.ventasreit.com.

A telephonic replay will be available at (800) 770-2030 (or +1 (609) 800-9909 for international callers), passcode 7655497, after the earnings call and will remain available for 30 days. The webcast replay will be posted in the Investor Relations section of www.ventasreit.com.

**<u>About Ventas</u>** 

Ventas, Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its more than 850 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OI<sup>TM</sup> platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas's seasoned

- MORE -

------

Ventas Reports 2025 Second Quarter Results

July 30, 2025

team of talented professionals shares a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.

**<u>Non-GAAP Financial Measures</u>**

This press release of Ventas, Inc. (the "Company," "we," "us," "our" and similar terms) includes certain financial performance measures not defined by generally accepted accounting principles in the United States ("GAAP"), such as Nareit FFO, Normalized FFO, Net Operating Income ("NOI"), Same-Store Cash NOI, Same-Store Cash NOI Growth and Net Debt to Further Adjusted EBITDA. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP measures are included in the appendix to this press release. Our definitions and calculations of these non-GAAP measures may not be the same as similar measures reported by other REITs.

These non-GAAP financial measures should not be considered as alternatives for, or superior to, financial measures calculated in accordance with GAAP.

**<u>Cautionary Statements</u>**

*Certain of the information contained herein, including intra-quarter operating information, has been provided by our operators and we have not verified this information through an independent investigation or otherwise. We have no reason to believe that this information is inaccurate in any material respect, but we cannot assure you of its accuracy.*

*This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, among others, statements of expectations, beliefs, future plans and strategies, anticipated results from operations and developments and other matters that are not historical facts. Forward-looking statements include, among other things, statements regarding our and our officers' intent, belief or expectation as identified by the use of phrases or words such as "assume," "may," "will," "project," "expect," "believe," "intend," "anticipate," "seek," "target," "forecast," "plan," "line-of-sight," "outlook," "potential," "opportunity," "estimate," "could," "would," "should" and other comparable and derivative terms or the negatives thereof.*

*Forward-looking statements are based on management's beliefs as well as on a number of assumptions concerning future events. You should not put undue reliance on these forward-looking statements, which are not a guarantee of performance and are subject to a number of uncertainties and other factors that could cause actual events or results to differ materially from those expressed or implied by the forward-looking statements. We do not undertake a duty to update these forward-looking statements, which speak only as of the date on which they are made. We urge you to carefully review the disclosures we make concerning risks and uncertainties that may affect our business and future financial performance, including those made below and in our filings with the Securities and Exchange Commission, such as in the sections titled "Cautionary Statements — Summary Risk Factors" and "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024 and our subsequent Quarterly Report on Form 10-Q.*

*Certain factors that could affect our future results and our ability to achieve our stated goals include, but are not limited to: (a) our exposure and the exposure of our managers, tenants and borrowers to complex and evolving governmental policy, laws and regulations, including relating to healthcare, data privacy, cybersecurity, international trade and environmental matters, the impact of such policies, laws and regulations on our and our managers', tenants' and borrowers' business and the challenges and expense associated with complying with such policies, laws and regulations; (b) the impact of market, macroeconomic, general economic conditions and fiscal policy on us, our managers, tenants and borrowers and in areas in which our properties are geographically concentrated, including changes in or elevated inflation, interest rates and exchange rates, labor market dynamics and rises in unemployment, tightening of lending standards and reduced availability of credit or capital, events that affect consumer confidence, our occupancy rates and resident fee revenues, and the actual and perceived state of the real estate markets and public and private capital markets; (c) the potential for significant general and commercial claims, legal actions, investigations, regulatory proceedings and enforcement actions that could subject us or our managers, tenants or borrowers to increased operating costs, uninsured liabilities, including fines and other penalties, reputational harm or significant operational limitations, including the loss or suspension of or moratoriums on accreditations, licenses or certificates of need, suspension of or nonpayment for new admissions, denial of* 

- MORE -

------

Ventas Reports 2025 Second Quarter Results

July 30, 2025

*reimbursement, suspension, decertification or exclusion from federal, state or foreign healthcare programs or the closure of facilities or communities; (d) our reliance on third-party managers and tenants to operate or exert substantial control over properties they manage for, or rent from, us, which limits our control and influence over such properties, their operations and their performance; (e) our reliance and the reliance of our managers, tenants and borrowers on the financial, credit and capital markets and the risk that those markets may be disrupted or become constrained; (f) our ability, and the ability of our managers, tenants and borrowers, to navigate the trends impacting our or their businesses and the industries in which we or they operate, including their ability to respond to the impact of the U.S. political environment on government funding and reimbursement programs, and the financial condition or business prospect of our managers, tenants and borrowers; (g) our ability to achieve the anticipated benefits and synergies from, and effectively integrate, our completed or anticipated acquisitions and investments; (h) the risk of bankruptcy, inability to obtain benefits from governmental programs, insolvency or financial deterioration of our managers, tenants borrowers and other obligors which may, among other things, have an adverse impact on the ability of such parties to make payments or meet their other obligations to us, which could have an adverse impact on our results of operations and financial condition; (i) the risk that the borrowers under our loans or other investments default or that, to the extent we are able to foreclose or otherwise acquire the collateral securing our loans or other investments, we will be required to incur additional expense or indebtedness in connection therewith, that the assets will underperform expectations or that we may not be able to subsequently dispose of all or part of such assets on favorable terms; (j) our current and future amount of outstanding indebtedness, and our ability to access capital and to incur additional debt which is subject to our compliance with covenants in instruments governing our and our subsidiaries' existing indebtedness; (k) risks related to the recognition of reserves, allowances, credit losses or impairment charges which are inherently uncertain and may increase or decrease in the future and may not represent or reflect the ultimate value of, or loss that we ultimately realize with respect to, the relevant assets, which could have an adverse impact on our results of operations and financial condition; (l) the risk that our management agreements or leases are not renewed or are renewed on less favorable terms, that our managers or tenants default under those agreements or that we are unable to replace managers or tenants on a timely basis or on favorable terms, if at all; (m) our ability to identify and consummate future investments in, or dispositions of, healthcare assets and effectively manage our portfolio opportunities and our investments in co-investment vehicles, joint ventures and minority interests, including our ability to dispose of such assets on favorable terms as a result of rights of first offer or rights of first refusal in favor of third parties; (n) risks related to development, redevelopment and construction projects, including costs associated with inflation, rising or elevated interest rates, labor conditions and supply chain pressures, and risks related to increased construction and development in markets in which our properties are located, including adverse effect on our future occupancy rates; (o) our ability to attract and retain talented employees; (p) the limitations and significant requirements imposed upon our business as a result of our status as a REIT and the adverse consequences (including the possible loss of our status as a REIT) that would result if we are not able to comply with such requirements; (q) the ownership limits contained in our certificate of incorporation with respect to our capital stock in order to preserve our qualification as a REIT, which may delay, defer or prevent a change of control of our company; (r) increases in our borrowing costs as a result of becoming more leveraged, including in connection with acquisitions or other investment activity and rising or elevated interest rates; (s) our exposure to various operational risks, liabilities and claims from our operating assets; (t) our dependency on a limited number of managers and tenants for a significant portion of our revenues and operating income; (u) our exposure to particular risks due to our specific asset classes and operating markets, such as adverse changes affecting our specific asset classes and the healthcare real estate sector, the competitiveness or financial viability of hospitals on or near the campuses where our outpatient medical buildings are located, our relationships with universities, the level of expense and uncertainty of our research tenants, and the limitation of our uses of some properties we own that are subject to ground lease, air rights or other restrictive agreements; (v) our ability to maintain a positive reputation for quality and service with our key stakeholders; (w) the availability, adequacy and pricing of insurance coverage provided by our policies and policies maintained by our managers, tenants, borrowers or other counterparties; (x) the risk of exposure to unknown liabilities from our investments in properties or businesses; (y) the occurrence of cybersecurity threats and incidents that could disrupt our or our managers', tenants' or borrower's operations, result in the loss of confidential or personal information or damage our business relationships and reputation; (z) the failure to maintain effective internal controls, which could harm our business, results of operations and financial condition; (aa) the impact of merger, acquisition and investment activity in the healthcare industry or otherwise affecting our managers, tenants or borrowers; (bb) disruptions to the management and operations of our business and the uncertainties caused by activist investors; (cc) the risk of catastrophic or extreme weather and other natural events and the physical effects of climate change; (dd) the risk of potential dilution resulting from future sales or issuances of our equity securities; and (ee) the other factors set forth in our periodic filings with the Securities and Exchange Commission.*

- MORE -

------

Ventas Reports 2025 Second Quarter Results

July 30, 2025

---

| | | |
|:---|:---|:---|
| **CONSOLIDATED BALANCE SHEETS** | **CONSOLIDATED BALANCE SHEETS** | **CONSOLIDATED BALANCE SHEETS** |
| **(In thousands, except per share amounts; dollars in USD; unaudited)** | **(In thousands, except per share amounts; dollars in USD; unaudited)** | **(In thousands, except per share amounts; dollars in USD; unaudited)** |
| | **As of June 30, 2025** | **As of December 31, 2024** |
| **Assets** | | |
| &nbsp;&nbsp;&nbsp;Real estate investments: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Land and improvements | $2841538 | $2775790 |
| &nbsp;&nbsp;&nbsp;&nbsp;Buildings and improvements | 29717624 | 28717990 |
| &nbsp;&nbsp;&nbsp;&nbsp;Construction in progress | 306033 | 336231 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquired lease intangibles | 1556165 | 1558751 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease assets | 302440 | 308019 |
|  | 34723800 | 33696781 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated depreciation and amortization | (11568396) | (11096236) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net real estate property | 23155404 | 22600545 |
| &nbsp;&nbsp;&nbsp;&nbsp;Secured loans receivable and investments, net | 183652 | 144872 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments in unconsolidated real estate entities | 626571 | 626122 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net real estate investments | 23965627 | 23371539 |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | 614200 | 897850 |
| &nbsp;&nbsp;&nbsp;Escrow deposits and restricted cash | 62557 | 59383 |
| &nbsp;&nbsp;&nbsp;Goodwill | 1046384 | 1044915 |
| &nbsp;&nbsp;&nbsp;Assets held for sale | 50092 | 18625 |
| &nbsp;&nbsp;&nbsp;Deferred income tax assets, net | 2167 | 1931 |
| &nbsp;&nbsp;&nbsp;Other assets | 733902 | 792663 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $26474929 | $26186906 |
| **Liabilities and equity** |  |  |
| &nbsp;&nbsp;&nbsp;Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Senior notes payable and other debt | $13056312 | $13522551 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued interest payable | 130407 | 143345 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | 217433 | 218003 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and other liabilities | 1132187 | 1152306 |
| &nbsp;&nbsp;&nbsp;&nbsp;Liabilities related to assets held for sale | 3442 | 2726 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax liabilities | 13988 | 8150 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 14553769 | 15047081 |
| &nbsp;&nbsp;&nbsp;Redeemable OP unitholder and noncontrolling interests | 328699 | 310229 |
| &nbsp;&nbsp;&nbsp;Commitments and contingencies |  |  |
| &nbsp;&nbsp;&nbsp;Equity: |  |  |
| &nbsp;&nbsp;Ventas stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred stock, $1.00 par value; 10,000 shares authorized, unissued |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.25 par value; 1,200,000 and 600,000 shares authorized at June 30, 2025 and December 31, 2024, respectively, 454,249 and 437,085 shares outstanding at June 30, 2025 and December 31, 2024, respectively | 113216 | 109119 |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital in excess of par value | 18701834 | 17607482 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (33804) | (33526) |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings (deficit) | (7208703) | (6886653) |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock, 280 and 4 shares issued at June 30, 2025 and December 31, 2024, respectively | (43155) | (25155) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Ventas stockholders' equity | 11529388 | 10771267 |
| &nbsp;&nbsp;&nbsp;Noncontrolling interests | 63073 | 58329 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total equity | 11592461 | 10829596 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and equity | $26474929 | $26186906 |

---

- MORE -

------

Ventas Reports 2025 Second Quarter Results

July 30, 2025

---

| | | | | |
|:---|:---|:---|:---|:---|
| **CONSOLIDATED STATEMENTS OF INCOME** | **CONSOLIDATED STATEMENTS OF INCOME** | **CONSOLIDATED STATEMENTS OF INCOME** | **CONSOLIDATED STATEMENTS OF INCOME** | **CONSOLIDATED STATEMENTS OF INCOME** |
| **(In thousands, except per share amounts; dollars in USD; unaudited)** | **(In thousands, except per share amounts; dollars in USD; unaudited)** | **(In thousands, except per share amounts; dollars in USD; unaudited)** | **(In thousands, except per share amounts; dollars in USD; unaudited)** | **(In thousands, except per share amounts; dollars in USD; unaudited)** |
| | **For the Three Months Ended June 30,** | **For the Three Months Ended June 30,** | **For the Six Months Ended June 30,** | **For the Six Months Ended June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| &nbsp;&nbsp;**Revenues** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Rental income: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Triple-net leased properties | $152702 | $153934 | $308815 | $309302 |
| &nbsp;&nbsp;&nbsp;&nbsp;Outpatient medical and research portfolio | 220814 | 218853 | 442133 | 437730 |
|  | 373516 | 372787 | 750948 | 747032 |
| &nbsp;&nbsp;&nbsp;Resident fees and services | 1032714 | 817600 | 2001618 | 1630904 |
| &nbsp;&nbsp;&nbsp;Third-party capital management revenues | 4397 | 4332 | 8733 | 8628 |
| &nbsp;&nbsp;&nbsp;Income from loans and investments | 4395 | 1436 | 8719 | 2725 |
| &nbsp;&nbsp;&nbsp;Interest and other income | 5871 | 4825 | 8949 | 11605 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 1420893 | 1200980 | 2778967 | 2400894 |
| &nbsp;&nbsp;**Expenses** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest | 150298 | 149259 | 299654 | 299192 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 347719 | 339848 | 669244 | 640103 |
| &nbsp;&nbsp;&nbsp;Property-level operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Senior housing | 746302 | 603359 | 1450702 | 1213180 |
| &nbsp;&nbsp;&nbsp;&nbsp;Outpatient medical and research portfolio | 75001 | 73286 | 150958 | 147224 |
| &nbsp;&nbsp;&nbsp;&nbsp;Triple-net leased properties | 3966 | 3506 | 7493 | 7244 |
|  | 825269 | 680151 | 1609153 | 1367648 |
| &nbsp;&nbsp;&nbsp;Third-party capital management expenses | 1627 | 1650 | 3452 | 3403 |
| &nbsp;&nbsp;&nbsp;General, administrative and professional fees | 42856 | 37727 | 96005 | 86464 |
| &nbsp;&nbsp;&nbsp;Loss on extinguishment of debt, net |  | 420 |  | 672 |
| &nbsp;&nbsp;&nbsp;Transaction, transition and restructuring costs | 4627 | 2886 | 10609 | 7563 |
| &nbsp;&nbsp;&nbsp;Recovery of allowance on loans receivable and investments, net |  | (42) |  | (110) |
| &nbsp;&nbsp;&nbsp;Shareholder relations matters |  | 37 |  | 15751 |
| &nbsp;&nbsp;&nbsp;Other expense | 5839 | 8128 | 7251 | 6794 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total expenses | 1378235 | 1220064 | 2695368 | 2427480 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income (loss) before unconsolidated entities, real estate dispositions, income taxes and noncontrolling interests | 42658 | (19084) | 83599 | (26586) |
| &nbsp;&nbsp;&nbsp;Loss from unconsolidated entities | (1138) | (1652) | (4449) | (10035) |
| &nbsp;&nbsp;&nbsp;Gain on real estate dispositions | 33816 | 49670 | 33985 | 50011 |
| &nbsp;&nbsp;&nbsp;Income tax (expense) benefit | (3874) | (7766) | 6683 | (4762) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | 71462 | 21168 | 119818 | 8628 |
| &nbsp;&nbsp;&nbsp;Net income attributable to noncontrolling interests | 3198 | 1781 | 4686 | 3553 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to common stockholders | $68264 | $19387 | $115132 | $5075 |
| &nbsp;&nbsp;**Earnings per common share** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | $0.16 | $0.05 | $0.27 | $0.02 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to common stockholders | 0.15 | 0.05 | 0.26 | 0.01 |
| &nbsp;&nbsp;&nbsp;Diluted: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | $0.16 | $0.05 | $0.26 | $0.02 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to common stockholders | 0.15 | 0.05 | 0.25 | 0.01 |
| &nbsp;&nbsp;**Weighted average shares used in computing earnings per common share** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 452583 | 408097 | 446314 | 405747 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 459088 | 411823 | 453000 | 409472 |

---

- MORE -

------

Ventas Reports 2025 Second Quarter Results

July 30, 2025

**NON-GAAP FINANCIAL MEASURES RECONCILIATION**

**Funds From Operations Attributable to Common Stockholders (FFO)**

**(In thousands, except per share amounts; dollars in USD; totals may not sum due to rounding; unaudited)**

---

| | | | |
|:---|:---|:---|:---|
| | **For the Three Months Ended June 30,** | **For the Three Months Ended June 30,** | **Q2 YoY Change** |
| | **2025** | **2024** | **'25-'24** |
| **Net income attributable to common stockholders** | $**68264** | $**19387** | **252%** |
| ***Net income attributable to common stockholders per share*** | $***0.15*** | $***0.05*** | ***200%*** |
| Adjustments: |  |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization on real estate assets | 346214 | 339186 |  |
| &nbsp;&nbsp;&nbsp;Depreciation on real estate assets related to noncontrolling interests | (3973) | (3723) |  |
| &nbsp;&nbsp;&nbsp;Depreciation on real estate assets related to unconsolidated entities | 18716 | 12012 |  |
| &nbsp;&nbsp;&nbsp;Gain on real estate dispositions | (33816) | (49670) |  |
| &nbsp;&nbsp;&nbsp;Gain on real estate dispositions related to unconsolidated entities | (62) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Subtotal: Nareit FFO adjustments | 327079 | 297805 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;*Subtotal: Nareit FFO adjustments per share* | $*0.71* | $*0.72* |  |
| **Nareit FFO attributable to common stockholders** | $**395343** | $**317192** | **25%** |
| ***Nareit FFO attributable to common stockholders per share*** | $***0.86*** | $***0.77*** | ***12%*** |
| Adjustments: |  |  |  |
| &nbsp;&nbsp;&nbsp;(Gain) loss on derivatives, net | (1074) | 1387 |  |
| &nbsp;&nbsp;&nbsp;Non-cash impact of income tax benefit | 748 | 6074 |  |
| &nbsp;&nbsp;&nbsp;Loss on extinguishment of debt, net |  | 420 |  |
| &nbsp;&nbsp;&nbsp;Transaction, transition and restructuring costs | 4627 | 2886 |  |
| &nbsp;&nbsp;&nbsp;Amortization of other intangibles | 121 | 96 |  |
| &nbsp;&nbsp;&nbsp;Non-cash impact of changes to executive equity compensation plan | (1042) | (2366) |  |
| &nbsp;&nbsp;&nbsp;Significant disruptive events, net | 958 | 2363 |  |
| &nbsp;&nbsp;&nbsp;Recovery of allowance on loans receivable and investments, net |  | (42) |  |
| &nbsp;&nbsp;&nbsp;Normalizing items related to noncontrolling interests and unconsolidated entities, net | 463 | 770 |  |
| &nbsp;&nbsp;Other normalizing items, net <sup>(1)</sup> | (1) | 339 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Subtotal: Normalized FFO adjustments | 4800 | 11927 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;*Subtotal: Normalized FFO adjustments per share* | 0.01 | 0.03 |  |
| **Normalized FFO attributable to common stockholders** | $**400143** | $**329119** | **22%** |
| ***Normalized FFO attributable to common stockholders per share*** | $***0.87*** | $***0.80*** | ***9%*** |
| Weighted average diluted shares | 459088 | 411823 |  |

---

______________________________

n/m - Not meaningful

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;For the three months ended June 30, 2024, primarily related to shareholder relations matters and certain legal matters.

- MORE -

------

Ventas Reports 2025 Second Quarter Results

July 30, 2025

Historical cost accounting for real estate assets implicitly assumes that the value of real estate assets diminishes predictably over time. However, since real estate values historically have risen or fallen with market conditions, many industry investors deem presentations of operating results for real estate companies that use historical cost accounting to be insufficient by themselves. For that reason, the Company considers Funds From Operations attributable to common stockholders ("FFO") and Normalized FFO attributable to common stockholders ("Normalized FFO") to be appropriate supplemental measures of operating performance of an equity REIT. The Company believes that the presentation of FFO, combined with the presentation of required GAAP financial measures, has improved the understanding of operating results of REITs among the investing public and has helped make comparisons of REIT operating results more meaningful. Management generally considers FFO to be a useful measure for understanding and comparing our operating results because, by excluding gains and losses related to sales of previously depreciated operating real estate assets, impairment losses on depreciable real estate and real estate asset depreciation and amortization (which can differ across owners of similar assets in similar condition based on historical cost accounting and useful life estimates), FFO can help investors compare the operating performance of a company's real estate across reporting periods and to the operating performance of other companies. The Company believes that Normalized FFO is useful because it allows investors, analysts and Company management to compare the Company's operating performance across periods on a consistent basis. In some cases, the Company provides information about identified non-cash components of FFO and Normalized FFO because it allows investors, analysts and our management to assess the impact of those items on our financial results.

**Nareit Funds From Operations Attributable to Common Stockholders ("Nareit FFO")**

The Company uses the National Association of Real Estate Investment Trusts ("Nareit") definition of FFO. Nareit defines FFO as net income attributable to common stockholders (computed in accordance with GAAP) excluding gains (or losses) from sales of real estate property, including gain (or loss) on re-measurement of equity method investments and impairment write-downs of depreciable real estate, plus real estate depreciation and amortization, and after adjustments for unconsolidated entities and noncontrolling interests. Adjustments for unconsolidated entities and noncontrolling interests will be calculated to reflect FFO on the same basis.

**Normalized FFO Attributable to Common Stockholders ("Normalized FFO")**

The Company defines Normalized FFO as Nareit FFO excluding the following income and expense items, without duplication: (a) gains and losses on derivatives, net and changes in the fair value of financial instruments; (b) the non-cash impact of income tax benefits or expenses; (c) gains and losses on extinguishment of debt, net including the write-off of unamortized deferred financing fees or additional costs, expenses, discounts, make-whole payments, penalties or premiums incurred as a result of early retirement or payment of our debt; (d) transaction, transition and restructuring costs; (e) amortization of other intangibles; (f) the non-cash impact of changes to our executive equity compensation plan; (g) net expenses or recoveries related to significant disruptive events; (h) the impact of expenses related to asset impairment and valuation allowances; (i) the financial impact of contingent consideration; (j) gains and losses on non-real estate dispositions and other normalizing items related to noncontrolling interests and unconsolidated entities; and (k) other items set forth in the Normalized FFO reconciliation included herein.

Nareit FFO and Normalized FFO presented herein may not be comparable to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. Nareit FFO and Normalized FFO should not be considered as alternatives to net income attributable to common stockholders (determined in accordance with GAAP) as indicators of the Company's financial performance or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company's liquidity, nor are they necessarily indicative of sufficient cash flow to fund all of the Company's needs. The Company believes that in order to facilitate a clear understanding of the consolidated historical operating results of the Company, Nareit FFO and Normalized FFO should be examined in conjunction with net income attributable to common stockholders as presented elsewhere herein.

- MORE -

------

Ventas Reports 2025 Second Quarter Results

July 30, 2025

**NON-GAAP FINANCIAL MEASURES RECONCILIATION**

**Full Year 2025 Guidance as of July 30, 2025**<sup>1</sup> 

**Net Income and FFO Attributable to Common Stockholders**<sup>2</sup>

**(In millions, except per share amounts; dollars in USD; totals may not sum due to rounding; unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **FY 2025** | **FY 2025** | **FY 2025 - Per Share** | **FY 2025 - Per Share** |
| | **Low** | **High** | **Low** | **High** |
|<br>**Net income attributable to common stockholders** | **$215** | **$238** | **$0.47** | **$0.52** |
| Depreciation and amortization adjustments | 1377 | 1377 | $2.98 | $2.98 |
| Gain on real estate dispositions | (34) | (34) | ($0.07) | ($0.07) |
| **Nareit FFO attributable to common stockholders** | **$1558** | **$1581** | **$3.38** | **$3.43** |
| Other adjustments<sup>3</sup> | 15 | 15 | $0.03 | $0.03 |
| **Normalized FFO attributable to common stockholders** | **$1573** | **$1596** | **$3.41** | **$3.46** |
| &nbsp;&nbsp;&nbsp;*% Year-over-year growth* |  |  | *7%* | *8%* |
| Weighted average diluted shares (in millions) | 461 | 461 |  |  |

---

<sup>1</sup> The Company's guidance constitutes forward-looking statements within the meaning of the federal securities laws and is based on a number of assumptions that are subject to change and many of which are outside the control of the Company. Actual results may differ materially from the Company's expectations depending on factors discussed herein and in the Company's filings with the Securities and Exchange Commission.

<sup>2</sup> Totals may not add due to minor corporate-level adjustments.

<sup>3</sup> Other adjustments include the categories of adjustments presented in our "Non-GAAP Financial Measures Reconciliation – Funds From Operations Attributable to Common Stockholders (FFO)".

**<u>Select Guidance Assumptions:</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Company's guidance incorporates the following assumptions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Senior housing investment volume increased to $2.0 billion, from $1.5 billion

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;▪ ~$1.8 billion of equity raised, including ~$0.7 billion of unsettled equity forward sales agreements outstanding as of July 2025

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ General and administrative expenses of ~$178 million at midpoint

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Interest expense of ~$615 million at midpoint

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Interest and other income of ~$15 million at midpoint

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Full year weighted average diluted share count increased from 460 million to 461 million

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Disposition proceeds of ~$200 million

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ FAD capital expenditures of ~$285 million at midpoint

- MORE -

------

Ventas Reports 2025 Second Quarter Results

July 30, 2025

**NON-GAAP FINANCIAL MEASURES RECONCILIATION**

**Full Year 2025 Guidance as of May 28, 2025**<sup>1</sup> 

**Net Income and FFO Attributable to Common Stockholders**<sup>2</sup>

**(In millions, except per share amounts; dollars in USD; totals may not sum due to rounding; unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **FY 2025** | **FY 2025** | **FY 2025 - Per Share** | **FY 2025 - Per Share** |
| | **Low** | **High** | **Low** | **High** |
|<br>**Net income attributable to common stockholders** | **$196** | **$245** | **$0.43** | **$0.53** |
| Depreciation and amortization adjustments | 1311 | 1311 | $2.85 | $2.85 |
| **Nareit FFO attributable to common stockholders** | **$1507** | **$1556** | **$3.28** | **$3.38** |
| Other adjustments<sup>3</sup> | 36 | 36 | $0.08 | $0.08 |
| **Normalized FFO attributable to common stockholders** | **$1544** | **$1593** | **$3.36** | **$3.46** |
| &nbsp;&nbsp;&nbsp;*% Year-over-year growth* |  |  | *5%* | *8%* |
| Weighted average diluted shares (in millions) | 460 | 460 |  |  |

---

<sup>1</sup> The Company's guidance constitutes forward-looking statements within the meaning of the federal securities laws and is based on a number of assumptions that are subject to change and many of which are outside the control of the Company. Actual results may differ materially from the Company's expectations depending on factors discussed herein and in the Company's filings with the Securities and Exchange Commission.

<sup>2</sup> Totals may not add due to minor corporate-level adjustments.

<sup>3</sup> Other adjustments include the categories of adjustments presented in our "Non-GAAP Financial Measures Reconciliation – Funds From Operations Attributable to Common Stockholders (FFO)".

**<u>Select Guidance Assumptions:</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• On May 28, 2025, the Company improved its 2025 outlook for Normalized FFO per share, led by SHOP

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ SHOP Same-Store Cash NOI year-over-year growth range improved to 12% - 16%, from 11% - 16%

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• All other guidance assumptions remain the same, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Senior housing investment volume of $1.5 billion

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;▪ Investments funded primarily with existing unsettled forward equity commitments and disposition proceeds

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Full year weighted average diluted share count of 460 million

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Net disposition proceeds of ~$200 million

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ FAD capital expenditures of ~$285 million at midpoint

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ General and administrative expenses of ~$172 million at midpoint

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Net interest expense (i.e., interest expense net of interest and other income) expected to increase ~$32 million year-over-year due to refinancing maturing debt at higher rates and lower cash balances

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;▪ Interest expense of ~$618 million at midpoint

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;▪ Interest and other income of ~$11 million at midpoint

- MORE -

------

Ventas Reports 2025 Second Quarter Results

July 30, 2025

**NON-GAAP FINANCIAL MEASURES RECONCILIATION**

**Second Quarter 2025 Same-Store Cash NOI by Segment**

**(In thousands, unless otherwise noted; dollars in USD; totals may not sum due to rounding; unaudited)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **For the Three Months Ended June 30, 2025** | **For the Three Months Ended June 30, 2025** | **For the Three Months Ended June 30, 2025** | **For the Three Months Ended June 30, 2025** | **For the Three Months Ended June 30, 2025** |
| | **SHOP** | **OM&R** | **NNN** | **Non-Segment** | **Total** |
| **Net income attributable to common stockholders** |  |  |  |  | $**68264** |
| Adjustments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest and other income |  |  |  |  | (5871) |
| &nbsp;&nbsp;&nbsp;Interest expense |  |  |  |  | 150298 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization |  |  |  |  | 347719 |
| &nbsp;&nbsp;&nbsp;General, administrative and professional fees |  |  |  |  | 42856 |
| &nbsp;&nbsp;&nbsp;Transaction, transition and restructuring costs |  |  |  |  | 4627 |
| &nbsp;&nbsp;&nbsp;Other expense |  |  |  |  | 5839 |
| &nbsp;&nbsp;&nbsp;Loss from unconsolidated entities |  |  |  |  | 1138 |
| &nbsp;&nbsp;&nbsp;Gain on real estate dispositions |  |  |  |  | (33816) |
| &nbsp;&nbsp;&nbsp;Income tax expense |  |  |  |  | 3874 |
| &nbsp;&nbsp;&nbsp;Net income attributable to noncontrolling interests |  |  |  |  | 3198 |
| NOI | $286412 | $146486 | $148736 | $6492 | $588126 |
| Adjustments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Straight-lining of rental income |  | (2620) | (5579) |  | (8199) |
| &nbsp;&nbsp;&nbsp;Non-cash rental income |  | (1994) | (7720) |  | (9714) |
| &nbsp;&nbsp;&nbsp;Cash modification fees |  | 1043 |  |  | 1043 |
| &nbsp;&nbsp;NOI not included in cash NOI <sup>(1)</sup> | 853 | (1329) | (6107) |  | (6583) |
| &nbsp;&nbsp;&nbsp;Non-segment NOI |  |  |  | (6492) | (6492) |
| Cash NOI | $287265 | $141586 | $129330 | $— | $558181 |
| Adjustments: |  |  |  |  |  |
| &nbsp;&nbsp;Cash NOI not included in Same-Store | (61197) | (5674) | (5962) |  | (72833) |
| **Same-Store Cash NOI** | $**226068** | $**135912** | $**123368** | $**—** | $**485348** |
| *Percentage increase* | *13.3 %* | *1.7 %* | *1.0 %* |  | *6.6 %* |

---

&nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Includes consolidated properties. Excludes sold assets, assets owned by unconsolidated real estate entities, assets held for sale, loan repayments, development properties not yet operational, land parcels and third-party management revenues from all periods. Assets that have undergone business model transitions are reflected within the new business segment as of the transition date.

- MORE -

------

Ventas Reports 2025 Second Quarter Results

July 30, 2025

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **For the Three Months Ended June 30, 2024** | **For the Three Months Ended June 30, 2024** | **For the Three Months Ended June 30, 2024** | **For the Three Months Ended June 30, 2024** | **For the Three Months Ended June 30, 2024** |
| | **SHOP** | **OM&R** | **NNN** | **Non-Segment** | **Total** |
| **Net income attributable to common stockholders** |  |  |  |  | $**19387** |
| Adjustments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest and other income |  |  |  |  | (4825) |
| &nbsp;&nbsp;&nbsp;Interest expense |  |  |  |  | 149259 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization |  |  |  |  | 339848 |
| &nbsp;&nbsp;&nbsp;General, administrative and professional fees |  |  |  |  | 37727 |
| &nbsp;&nbsp;&nbsp;Loss on extinguishment of debt, net |  |  |  |  | 420 |
| &nbsp;&nbsp;&nbsp;Transaction, transition and restructuring costs |  |  |  |  | 2886 |
| &nbsp;&nbsp;&nbsp;Recovery of allowance on loans receivable and investments, net |  |  |  |  | (42) |
| &nbsp;&nbsp;&nbsp;Shareholder relations matters |  |  |  |  | 37 |
| &nbsp;&nbsp;&nbsp;Other expense |  |  |  |  | 8128 |
| &nbsp;&nbsp;&nbsp;Loss from unconsolidated entities |  |  |  |  | 1652 |
| &nbsp;&nbsp;&nbsp;Gain on real estate dispositions |  |  |  |  | (49670) |
| &nbsp;&nbsp;&nbsp;Income tax expense |  |  |  |  | 7766 |
| &nbsp;&nbsp;&nbsp;Net income attributable to noncontrolling interests |  |  |  |  | 1781 |
| NOI | $214241 | $146273 | $150428 | $3412 | $514354 |
| Adjustments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Straight-lining of rental income |  | (3482) | 744 |  | (2738) |
| &nbsp;&nbsp;&nbsp;Non-cash rental income |  | (2223) | (11538) |  | (13761) |
| &nbsp;&nbsp;&nbsp;Cash modification fees |  | 500 |  |  | 500 |
| &nbsp;&nbsp;NOI not included in cash NOI <sup>(1)</sup> | 1306 | (2456) | (16835) |  | (17985) |
| &nbsp;&nbsp;&nbsp;Non-segment NOI |  |  |  | (3412) | (3412) |
| &nbsp;&nbsp;&nbsp;NOI impact from change in FX | (533) |  | 194 |  | (339) |
| Cash NOI | $215014 | $138612 | $122993 | $— | $476619 |
| Adjustments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cash NOI not included in Same-Store | (15579) | (4936) | (844) |  | (21359) |
| &nbsp;&nbsp;&nbsp;NOI impact from change in FX not in Same-Store | 25 |  |  |  | 25 |
| **Same-Store Cash NOI** | $**199460** | $**133676** | $**122149** | $**—** | $**455285** |

---

&nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Includes consolidated properties. Excludes sold assets, assets owned by unconsolidated real estate entities, assets held for sale, loan repayments, development properties not yet operational, land parcels and third-party management revenues from all periods. Assets that have undergone business model transitions are reflected within the new business segment as of the transition date.

- MORE -

------

Ventas Reports 2025 Second Quarter Results

July 30, 2025

**NON-GAAP FINANCIAL MEASURES RECONCILIATION**

**Adjusted EBITDA and Net Debt**

**(Dollars in thousands USD; totals may not sum due to rounding; unaudited)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **For the Three Months Ended** | **For the Three Months Ended** | **For the Three Months Ended** | **For the Three Months Ended** | **For the Three Months Ended** | **For the Three Months Ended** |
| | **June 30, 2025** | **June 30, 2025** | **March 31, 2025** | **March 31, 2025** | **December 31, 2024** | **December 31, 2024** |
| **Net income attributable to common stockholders** | $**68264** |  | $**46868** |  | $**56835** |  |
| Adjustments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense | 150298 |  | 149356 |  | 153206 |  |
| &nbsp;&nbsp;&nbsp;Loss on extinguishment of debt, net |  |  |  |  | 15 |  |
| &nbsp;&nbsp;&nbsp;Taxes (including tax amounts in general, administrative and professional fees) | 4787 |  | (9601) |  | (44153) |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 347719 |  | 321525 |  | 308772 |  |
| &nbsp;&nbsp;&nbsp;Non-cash stock-based compensation expense | 7683 |  | 18827 |  | 4648 |  |
| &nbsp;&nbsp;&nbsp;Transaction, transition and restructuring costs | 4627 |  | 5982 |  | 4226 |  |
| &nbsp;&nbsp;Net income attributable to noncontrolling interests, adjusted for partners' share of consolidated entity EBITDA | (8030) |  | (7440) |  | (6902) |  |
| &nbsp;&nbsp;Income from unconsolidated entities, adjusted for Ventas' share of EBITDA from unconsolidated entities | 37418 |  | 32603 |  | 24368 |  |
| &nbsp;&nbsp;&nbsp;Gain on real estate dispositions | (33816) |  | (169) |  | (6727) |  |
| &nbsp;&nbsp;&nbsp;Unrealized foreign currency (gain) loss | (492) |  | (116) |  | 362 |  |
| &nbsp;&nbsp;&nbsp;(Gain) loss on derivatives, net | (1201) |  | (7926) |  | 21173 |  |
| &nbsp;&nbsp;&nbsp;Significant disruptive events, net | 958 |  | 4066 |  | 2603 |  |
| &nbsp;&nbsp;Other normalizing items, net <sup>(1)</sup> | (1) |  |  |  | 7446 |  |
| **Adjusted EBITDA** | $**578214** |  | $**553975** |  | $**525872** |  |
| &nbsp;&nbsp;&nbsp;Adjustment for current period activity | (3996) |  | 13059 |  | 15885 |  |
| **Further Adjusted EBITDA** | $**574218** |  | $**567034** |  | $**541757** |  |
| **Further Adjusted EBITDA annualized** | $**2296872** |  | $**2268136** |  | $**2167028** |  |
| **Total debt** | $**13056312** |  | $**12701675** |  | $**13522551** |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | (614200) |  | (182335) |  | (897850) |  |
| &nbsp;&nbsp;&nbsp;Restricted cash pertaining to debt | (34466) |  | (34607) |  | (32588) |  |
| &nbsp;&nbsp;&nbsp;Partners' share of consolidated debt | (326038) |  | (312650) |  | (310881) |  |
| &nbsp;&nbsp;&nbsp;Ventas's share of unconsolidated debt | 721462 |  | 692842 |  | 676839 |  |
| **Net debt** | $**12803070** |  | $**12864925** |  | $**12958071** |  |
| **Net Debt / Further Adjusted EBITDA** | **5.6** | **x** | **5.7** | **x** | **6.0** | **x** |

---

<sup>(1)</sup> For the three months ended December 31, 2024, primarily related to certain legal matters.

The Company believes that Net debt and Further Adjusted EBITDA are useful to investors, analysts and Company management because they allow the comparison of the Company's credit strength between periods and to other real estate companies without the effect of items that by their nature are not comparable from period to period.

- MORE -

------

Ventas Reports 2025 Second Quarter Results

July 30, 2025

**Adjusted EBITDA**

The Company defines Adjusted EBITDA as consolidated earnings before interest, taxes, depreciation and amortization (including non-cash stock-based compensation expense, asset impairment and valuation allowances), excluding (a) gains or losses on extinguishment of debt; (b) transaction, transition and restructuring costs; (c) noncontrolling interests' share of adjusted EBITDA; (d) net gains or losses on real estate activity; (e) gains or losses on re-measurement of equity interest upon acquisition; (f) unrealized foreign currency gains or losses; (g) gains or losses on derivatives, net and changes in the fair value of financial instruments; (h) net expenses or recoveries related to significant disruptive events; and including (x) Ventas' share of adjusted EBITDA from unconsolidated entities and (y) the impact of other items set forth in the Adjusted EBITDA reconciliation included herein.

**Further Adjusted EBITDA**

Further Adjusted EBITDA is Adjusted EBITDA further adjusted for transactions and events that were completed during the period, as if the transaction or event had been consummated at the beginning of the relevant period and considers any other incremental items set forth in the Further Adjusted EBITDA reconciliation included herein.

The Company considers NOI and Cash NOI as important supplemental measures because they allow investors, analysts and the Company's management to assess its unlevered property-level operating results and to compare its operating results with those of other real estate companies and between periods on a consistent basis.

**NOI**

The Company defines NOI as total revenues, less interest and other income, property-level operating expenses and third-party capital management expenses.

**Cash NOI**

The Company defines Cash NOI as NOI for its reportable business segments (i.e., SHOP, OM&R and NNN), determined on a Constant Currency basis, excluding the impact of, without duplication (i) non-cash items such as straight-line rent and the amortization of lease intangibles, (ii) sold assets, assets held for sale, development properties not yet operational and land parcels and (iii) other items set forth in the Cash NOI reconciliation included herein. In certain cases, results may be adjusted to reflect the receipt of cash payments, fees, and other consideration that is not fully recognized as NOI in the period.

**Same-Store**

The Company defines same-store as properties owned, consolidated and operational for the full period in both comparison periods and that are not otherwise excluded; provided, however, that the Company may include selected properties that otherwise meet the same-store criteria if they are included in substantially all of, but not a full, period for one or both of the comparison periods, and in the Company's judgment such inclusion provides a more meaningful presentation of its segment performance.

Newly acquired development properties and recently developed or redeveloped properties in the Company's SHOP reportable business segment will be included in same-store once they are stabilized for the full period in both periods presented. These properties are considered stabilized upon the earlier of (a) the achievement of 80% sustained occupancy or (b) 24 months from the date of acquisition or substantial completion of work. Recently developed or redeveloped properties in the Company's OM&R and NNN reportable business segments will be included in same-store once substantial completion of work has occurred for the full period in both periods presented. Our SHOP and NNN that have undergone operator or business model transitions will be included in same-store once operating under consistent operating structures for the full period in both periods presented.

Properties are excluded from same-store if they are: (i) sold, classified as held for sale or properties whose operations were classified as discontinued operations in accordance with GAAP; (ii) impacted by significant disruptive events such as flood or fire; (iii) for SHOP, those properties that are currently undergoing a significant disruptive redevelopment; (iv) for OM&R and NNN reportable business segments, those properties for which management has an intention to institute, or has instituted, a redevelopment plan because the properties may require major property-level expenditures to maximize value, increase NOI, or maintain a market-competitive position and/or achieve property stabilization, most commonly as the result of an expected or actual material

- MORE -

------

Ventas Reports 2025 Second Quarter Results

July 30, 2025

change in occupancy or NOI; or (v) for SHOP and NNN reportable business segments, those properties that are scheduled to undergo operator or business model transitions, or have transitioned operators or business models after the start of the prior comparison period.

**Constant Currency**

To eliminate the impact of exchange rate movements, all portfolio performance-based disclosures assume constant exchange rates across comparable periods, using the following methodology: the current period's results are shown in actual reported USD, while prior comparison period's results are adjusted and converted to USD based on the average monthly exchange rate for the current period.

**Contacts**

BJ Grant

(877) 4-VENTAS

Source: Ventas, Inc.

- END -